🧪 Hypotheses

unknown 0.00

LAMP2A Upregulation to Enhance Chaperone-Mediated Autophagy for Tau Clearance in Alzheimer's Disease

🧬 LAMP2A 🏥 proteomics 📖 0🏛 1

✅ 0.00 ✨ 0.00 💥 0.00

Age-related decline in chaperone-mediated autophagy (CMA) contributes to the selective accumulation of hyperphosphorylated tau species in Alzheimer's ...

unknown 0.00

H6-V1: Aberrant eIF2α Phosphorylation Drives Mitochondrial Translation Dysfunction

🧬 EIF2S1, EIF2AK3/PERK, PPP1R15B, EIF2B, MRPL12, MRPS18B, TUFM 🏥 neurodegeneration 📖 9🏛 1

✅ 0.00 ✨ 0.00 💥 0.00

The eukaryotic initiation factor 2α (eIF2α) phosphorylation pathway critically regulates both cytoplasmic and mitochondrial protein synthesis, with mi...

therapeutic 0.00

CYP46A1-Mediated Cholesterol Reduction Prevents eIF2α-Driven Translation Stalling in Neurodegeneration

🧬 CYP46A1 🏥 neurodegeneration 📖 47🏛 3

✅ 0.00 ✨ 0.00 💥 0.00

This hypothesis proposes that CYP46A1 overexpression gene therapy prevents neurodegeneration by disrupting the pathological link between cholesterol d...

combination 0.00

LDLR-Mediated Neurosteroid Precursor Delivery Strategy

🧬 LDLR 🏥 neuropharmacology 📖 15🏛 1

✅ 0.00 ✨ 0.00 💥 0.00

The LDLR-Mediated Neurosteroid Precursor Delivery Strategy proposes utilizing the low-density lipoprotein receptor (LDLR) not for antibody transport, ...

therapeutic 0.00

CYP46A1 Small Molecule Activator Therapy

🧬 CYP46A1 🏥 neurodegeneration 📖 47🏛 3

✅ 0.00 ✨ 0.00 💥 0.00

This approach employs pharmacological activation of endogenous CYP46A1 rather than gene overexpression to treat Alzheimer's disease through enhanced b...

therapeutic 0.97

Closed-loop transcranial focused ultrasound targeting EC-II SST interneurons to restore hippocampal gamma oscillations v

🧬 SST 🏥 Alzheimer's disease 📖 50🏛 3

✅ 0.00 ✨ 0.60 💥 0.00

## Mechanistic Overview...

mechanistic 0.96

GluN2B-Mediated Thalamocortical Control of Glymphatic Tau Clearance

🧬 GRIN2B 🏥 neuroscience 📖 19🏛 4

✅ 0.85 ✨ 0.78 💥 0.82

## Mechanistic Overview...

therapeutic 0.96

Closed-loop optogenetic targeting PV interneurons to restore theta-gamma coupling and prevent amyloid-induced synaptic d

🧬 PVALB 🏥 Alzheimer's disease 📖 50🏛 3

✅ 0.00 ✨ 0.50 💥 0.00

## Mechanistic Overview...

therapeutic 0.95

Gamma entrainment therapy to restore hippocampal-cortical synchrony

🧬 SST 🏥 Alzheimer's disease 📖 57🏛 2

✅ 0.88 ✨ 0.78 💥 0.80

## Mechanistic Overview...

unknown 0.94

Plasma NfL Elevation Secondary to BBB-Associated Transport Dysfunction Enables Longitudinal Neurodegeneration Tracking

🧬 NEFL 🏥 N/A 📖 15🏛 1

✅ 0.55 ✨ 0.48 💥 0.00

Neurofilament light chain (NfL) is released from damaged neurofilaments into the extracellular space, flowing into CSF and ultimately into peripheral ...

mechanistic 0.92

Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming in Neurodegeneration

🧬 NLRP3, CASP1, IL1B, PYCARD 🏥 neurodegeneration 📖 34🏛 1

✅ 0.72 ✨ 0.50 💥 0.00

## Mechanistic Overview...

therapeutic 0.91

Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscillations via cholecystokinin interneuron ne

🧬 CCK 🏥 Alzheimer's disease 📖 50🏛 2

✅ 0.00 ✨ 0.64 💥 0.00

## Mechanistic Overview...

therapeutic 0.89

APOE-Dependent Autophagy Restoration

🧬 MTOR 🏥 neurodegeneration 📖 44🏛 3

✅ 0.90 ✨ 0.60 💥 0.80

## Mechanistic Overview...

unknown 0.89

Hypothesis 4: Metabolic Coupling via Lactate-Shuttling Collapse

🧬 SLC16A1, SLC16A7, LDHA, PDHA1 🏥 neurodegeneration 📖 9🏛 1

✅ 0.70 ✨ 0.62 💥 0.68

## Mechanistic Overview...

combination 0.89

p38α Inhibitor and PRMT1 Activator Combination to Restore Physiological TDP-43 Phosphorylation-Methylation Balance

🧬 MAPK14/PRMT1 🏥 neurodegeneration 📖 16🏛 1

✅ 0.78 ✨ 0.65 💥 0.82

## Mechanistic Overview...

mechanistic 0.89

SIRT1-Mediated Reversal of TREM2-Dependent Microglial Senescence

🧬 SIRT1 🏥 neurodegeneration 📖 54🏛 3

✅ 0.80 ✨ 0.70 💥 0.76

## Mechanistic Overview...

mechanistic 0.89

TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegeneration

🧬 TREM2 🏥 neurodegeneration 📖 1🏛 3

✅ 0.68 ✨ 0.72 💥 0.82

## Mechanistic Overview...

mechanistic 0.89

ACSL4-Driven Ferroptotic Priming in Disease-Associated Microglia

🧬 ACSL4 🏥 Alzheimer's Disease 📖 41🏛 3

✅ 0.75 ✨ 0.85 💥 0.85

## Mechanistic Overview...

combination 0.89

Multi-Target Hypothesis: Aβ-Induced Cholinergic Damage is Partially Irreversible

🧬 APP/PSEN1 (Aβ production), CHAT (cholinergic synthesis) 🏥 N/A 📖 18🏛 1

✅ 0.60 ✨ 0.55 💥 0.85

## Mechanistic Overview...

unknown 0.89

Optimized Temporal Window for Metabolic Boosting Therapy Determines Success of Microglial State Transition Restoration

🧬 IFNG 🏥 neurodegeneration 📖 10🏛 1

✅ 0.50 ✨ 0.75 💥 0.75

## Mechanistic Overview...

unknown 0.89

TREM2-APOE Axis Dissociation for Selective DAM Activation

🧬 TREM2-APOE axis 🏥 neurodegeneration 📖 23🏛 1

✅ 0.35 ✨ 0.78 💥 0.68

## Mechanistic Overview...

therapeutic 0.89

Hippocampal CA3-CA1 synaptic rescue via DHHC2-mediated PSD95 palmitoylation stabilization

🧬 BDNF 🏥 Alzheimer's disease 📖 1🏛 3

✅ 0.70 ✨ 0.82 💥 0.83

## Mechanistic Overview...

therapeutic 0.88

Beta-frequency entrainment therapy targeting PV interneuron-astrocyte coupling for tau clearance

🧬 SST 🏥 Alzheimer's disease 📖 50🏛 2

✅ 0.85 ✨ 0.82 💥 0.82

## Mechanistic Overview...

therapeutic 0.88

Circadian Glymphatic Entrainment via Targeted Orexin Receptor Modulation

🧬 HCRTR1/HCRTR2 🏥 neurodegeneration 📖 27🏛 2

✅ 0.90 ✨ 0.75 💥 0.80

## Mechanistic Overview...

unknown 0.88

TBK1 Loss Locks Microglia in an Aged/Senescent Transcriptional State, Fueling ALS-Associated SASP

🧬 TBK1 → NF-κB / IRF3 / p62-autophagy / cGAS-STING axis 🏥 ALS 📖 4🏛 2

✅ 0.80 ✨ 0.82 💥 0.50

The hypothesis proposes that loss-of-function mutations in TBK1 contribute to ALS pathogenesis by trapping microglia in a senescent, pro-inflammatory ...

therapeutic 0.87

Closed-loop tACS targeting EC-II parvalbumin interneurons to restore gamma rhythmogenesis and block tau AIS disruption i

🧬 PVALB 🏥 Alzheimer's disease 📖 50🏛 2

✅ 0.86 ✨ 0.79 💥 0.80

## Mechanistic Overview...

unknown 0.87

Complement Cascade Inhibition Synaptic Protection

🧬 N/A 🏥 neurodegeneration 📖 33🏛 1

✅ 0.55 ✨ 0.70 💥 0.72

## Mechanistic Overview...

therapeutic 0.87

Closed-loop transcranial focused ultrasound to restore hippocampal gamma oscillations via direct PV interneuron recruitm

🧬 PVALB 🏥 Alzheimer's disease 📖 65🏛 3

✅ 0.82 ✨ 0.78 💥 0.75

## Mechanistic Overview...

therapeutic 0.87

Optogenetic restoration of hippocampal gamma oscillations via selective PV interneuron activation using implantable LED

🧬 PVALB 🏥 Alzheimer's disease 📖 57🏛 3

✅ 0.45 ✨ 0.78 💥 0.68

## Mechanistic Overview...

unknown 0.87

Gamma Oscillation Entrainment Enhances lncRNA-9969-Mediated Autophagy Through PV Interneuron-Specific ceRNA Networks

🧬 PVALB, CREB1, lncRNA-9969, neuronal autophagy pathway 🏥 molecular neurobiology 📖 23🏛 1

✅ 0.55 ✨ 0.70 💥 0.65

## Mechanistic Overview...